Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis.
Fan Z, Wirth AK, Chen D, Wruck CJ, Rauh M, Buchfelder M, Savaskan N. · 2017
Read Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis. by Fan Z, Wirth AK, Chen D, Wruck CJ, Rauh M, Buchfelder M, Savaskan N. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5608917.txt.
Description
Fan and co-authors study a redox pathway in glioblastoma, a severe brain tumor. Their work ran in Oncogenesis. The pathway centers on Nrf2 and its brake, Keap1. Nrf2 switches on genes that guard cells from stress. In tumor cells, that guard can help the cancer grow and spread.
Patients with high Nrf2 levels lived shorter lives, the team reports. Raising Nrf2 or lowering Keap1 made glioma cells grow and change faster. The pathway also raised xCT, a pump that moves glutamate out of cells. That shift changed the space around the tumor. Cells with a stronger pathway also resisted ferroptosis, an iron-linked form of cell death. The authors name Nrf2 as a drug target that could make cancer drugs work better.
Catalog record
| CREATOR | Fan Z, Wirth AK, Chen D, Wruck CJ, Rauh M, Buchfelder M, Savaskan N. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 59 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |